Understanding Cellular Therapy: How Cells Heal
The traditional understanding of stem cell therapy focused on differentiation-the idea that injected stem cells would transform into disc cells, cartilage cells, or bone cells to replace damaged tissue. While differentiation does occur, recent research has revealed that the paracrine effect may be equally or more important. MSCs secrete a rich array of bioactive molecules that:
- Modulate inflammation by shifting macrophage phenotype from M1 (destructive) to M2 (reparative)
- Promote angiogenesis and nutrient delivery to ischemic tissue
- Recruit additional repair cells from surrounding tissue and circulation
- Provide neurotrophic support for nerve healing
- Produce anti-fibrotic signals that prevent scar tissue formation
Cells reprogram tissue environment, not just replace damaged tissue. This paracrine understanding has transformed how we think about cellular therapy. The cells are not just building blocks-they are signaling factories that reprogram the local biological environment from degenerative to regenerative.
Two Autologous Cell Sources: BMAC & Adipose-Derived MSCs
Bone marrow aspirate concentrate (BMAC) provides a concentrated source of MSCs along with hematopoietic progenitors, growth factors, and anti-inflammatory cytokines. BMAC-derived MSCs have strong osteogenic and chondrogenic differentiation potential, making them particularly suited for disc repair, cartilage regeneration, and bone healing applications.
Adipose-derived mesenchymal stem cells are harvested from the patient's own fat tissue via a minimally invasive lipoaspirate procedure. Adipose tissue contains a high density of MSCs-often 100 to 500 times more MSCs per volume than bone marrow. Adipose-derived MSCs excel at anti-inflammatory paracrine signaling and immunomodulation, and they show strong capacity for soft tissue repair.
In my practice, I often combine both autologous sources in a single treatment session. BMAC provides the osteogenic and chondrogenic machinery for disc and joint repair, while adipose-derived MSCs amplify the anti-inflammatory and immunomodulatory signaling. This combination approach-using your body's two richest autologous stem cell reservoirs together-is a key differentiator of our practice and one of the most powerful biological interventions available for spinal degeneration.
The Relationship Between Cellular Therapy and Exosomes
One of the most exciting developments in regenerative medicine is the recognition that exosomes-nanoscale vesicles secreted by MSCs-may mediate much of cellular therapy's therapeutic effect. Exosomes carry microRNA, proteins, and lipids that modulate gene expression and cellular behavior in target tissues. This suggests that the future of cellular therapy may involve not just delivering cells, but harnessing and optimizing the signaling molecules those cells produce.
Understanding this relationship informs how I use cellular therapy today. When I deliver BMAC to a degenerating disc, I am not simply providing cells-I am providing a complex biological package that includes cells, growth factors, cytokines, and exosomes working in concert. This integrated approach is what makes cellular therapy more potent than growth factors alone.
Conditions Treated
Regenerative cellular therapy is appropriate for advanced degenerative conditions where PRP alone provides insufficient biological stimulus. These include:
- Advanced disc degeneration
- Spinal stenosis with significant degenerative contribution
- Advanced facet arthropathy
- Chronic neuropathic pain with neuroinflammatory contribution
- Non-healing pars fractures